Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

Synthesis and Biological Evaluation of New 2-(4-Fluorophenyl) Imidazol-5-ones as Anticancer Agents

Yasmin A. Abo-Elanwar, Amany S. Mostafa, Magda A. A. El-Sayed, Magda N. A. Nasr.

Two series of imidazolones were designed, synthesized, and evaluated for their anticancer activity against four cancer cell lines; Hela, MCF-7, PC3 and HCT-116, where four compounds 6, 25, 26 and 29 showed good potency against the whole panel. Compound 30 showed a cytotoxic effect against PC3 cell lines comparable to that of the standard doxorubicin with IC50= 8.15然; while compounds 4 and 18 showed moderate activity with IC50 range of 10.58-11.45 然. Enzyme inhibition assay was implemented against CDK2A and VEGFR-2 that gave varied activities. Compound 6 exhibited the highest inhibitory activity against VEGFR-2; with IC50 value of 67 nM and moderate inhibition against CDK2A, while compound 26 achieved the best result against CDK2A with IC50 value of 0.66 然.

Key words: Imidazlone; Chalcones; Anticancer; VEGFR-2; CDK2A

Share this Article

Oxidants and Antioxidants in Medical Science


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.